Literature DB >> 28437633

MicroRNA-500a promotes migration and invasion in hepatocellular carcinoma by activating the Wnt/β-catenin signaling pathway.

Yuntao Guo1, Liwen Chen2, Chengyi Sun3, Chao Yu4.   

Abstract

Increased expression of microRNA-500a (miR-500a) has been reported in the serum of hepatocellular carcinoma (HCC) patients. However, the biological effects and mechanisms of miR-500a in hepatoma cells remain unclear. In this study, we found that miR-500a expression was up-regulated in HCC cell lines and tissues, and that high levels of miR-500a was associated with poor prognosis. We found that miR-500a upregulation promoted migration and invasion in two hepatoma cell lines, HCCLM3 and SMMC7721, while miR-500a downregulation had the opposite effect. We demonstrated that miR-500a activates the Wnt/β-catenin signaling pathway by directly binding to the 3'-untranslated region (UTR) of SFRP2 and GSK-3β mRNA. In conclusion, our results indicate miR-500a promotes HCC migration and invasion through activating Wnt/β-catenin signaling by directly binding to SFPR2 and GSK-3β.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma; Invasion; Migration; Wnt/β-catenin pathway; miR-500a

Mesh:

Substances:

Year:  2017        PMID: 28437633     DOI: 10.1016/j.biopha.2017.04.018

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  9 in total

1.  Serum MicroRNA Biomarkers Regulated by Simvastatin in a Primate Model of Endometriosis.

Authors:  Emine Cosar; Ramanaiah Mamillapalli; Irene Moridi; Antoni Duleba; Hugh S Taylor
Journal:  Reprod Sci       Date:  2018-03-27       Impact factor: 3.060

2.  lncRNA NEAT1 regulates gastric carcinoma cell proliferation, invasion and apoptosis via the miR‑500a‑3p/XBP‑1 axis.

Authors:  Yun Zhou; Zhenghong Sha; Yong Yang; Shuimei Wu; Hong Chen
Journal:  Mol Med Rep       Date:  2021-05-13       Impact factor: 2.952

3.  Telomerase reverse transcriptase activates transcription of miR500A to inhibit Hedgehog signalling and promote cell invasiveness.

Authors:  Manuel Bernabé-García; Elena Martínez-Balsalobre; Diana García-Moreno; Jesús García-Castillo; Beatriz Revilla-Nuin; Elena Blanco-Alcaina; Victoriano Mulero; Francisca Alcaraz-Pérez; María L Cayuela
Journal:  Mol Oncol       Date:  2021-05-02       Impact factor: 6.603

4.  Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28.

Authors:  Bing Chen; Yuting Sang; Xiaojin Song; Dong Zhang; Lijuan Wang; Wenjing Zhao; Yiran Liang; Ning Zhang; Qifeng Yang
Journal:  Theranostics       Date:  2021-02-06       Impact factor: 11.556

5.  miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma.

Authors:  Chunlin Jiang; Jianting Long; Baoxian Liu; Ming Xu; Wei Wang; Xiaoyan Xie; Xiaolin Wang; Ming Kuang
Journal:  J Exp Clin Cancer Res       Date:  2017-07-27

6.  Exosomal MiR-500a-3p promotes cisplatin resistance and stemness via negatively regulating FBXW7 in gastric cancer.

Authors:  Hao Lin; Liang Zhang; Caihua Zhang; Pengpeng Liu
Journal:  J Cell Mol Med       Date:  2020-06-25       Impact factor: 5.310

7.  miR-500a-3p is a Potential Prognostic Biomarker in Hepatocellular Carcinoma.

Authors:  Jianting Long; Baoxian Liu; Zhijia Yao; Huiwen Weng; Heping Li; Chunlin Jiang; Shi Fang
Journal:  Int J Gen Med       Date:  2022-02-21

8.  MiR‑500a‑5p promotes glioblastoma cell proliferation, migration and invasion by targeting chromodomain helicase DNA binding protein 5.

Authors:  Zhiyong Liu; Danying Su; Xiuying Qi; Jing Ma
Journal:  Mol Med Rep       Date:  2018-07-09       Impact factor: 2.952

9.  Effect of supercritical carbon dioxide fluid extract from Chrysanthemum indicum Linné on bleomycin-induced pulmonary fibrosis.

Authors:  Juan Nie; Yanlu Liu; Chaoyue Sun; Jingna Zheng; Baoyi Chen; Jianyi Zhuo; Ziren Su; Xiaoping Lai; Jiannan Chen; Jibiao Zheng; Yucui Li
Journal:  BMC Complement Med Ther       Date:  2021-09-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.